Parent company
There was no significant revenue. The loss for the first half amounted to EUR million (EUR million). At 30 June 2026 EUR million (EUR million) has been utilised under the social commercial paper programme. The proceeds of the programme have been lent to the Company’s subsidiary on the same maturity as the programme drawings. Equity as at 30 June 2026 was EUR million (EUR million).
Risks
The Group’s business is exposed to risks that could impact its operations, performance or financial position. Management of these risks enables Medicover to execute its strategy, maintain its ethical reputation, reach financial targets and secure continuous development and profitability in the long term. Group entities monitor and manage risks in its operations. In addition, the Group has a centralised enterprise risk management process, which is a systematic and structured framework used to identify, assess, measure, manage/mitigate, monitor and report risks. Identified risks are categorised as follows:
Operational risks – such as artificial intelligence, armed conflict and geopolitical risk, clinical quality, data loss or breach, environmental and climate-related risks, insurance risk (insurance business), IT systems failure and cybersecurity, market risk, medical workforce shortage and natural disaster.
Strategy and M&A risks – such as M&A due diligence and post-acquisition integration.
Financial risks – such as credit risk, foreign currency risk, interest rate risk and liquidity and refinancing risk.
Legal, compliance and political risks – such as anti-bribery and corruption.
Further information on risks and risk management is available in the annual report 2025, section ‘Risks and risk management’ (pages 61-69).